Long-term follow-up of cystinosis patients treated with 0.55% cysteamine hydrochloride.
Hong LiangAntoine LabbéChristophe BaudouinCeline PlissonVincenzo GiordanoPublished in: The British journal of ophthalmology (2020)
This large safety cohort confirms the efficacy, safety and tolerability of Cystadrops in real-world clinical practice.